CVDにおける病理学的ケモカインの標的化:CCL2およびCXCL8に対するサフランの役割
Yousef Baghcheghi1,2, Ahmad Golkar3, Ali Moghbeli2
1Bio Environmental Health Hazards Research Center, Jiroft University of Medical Sciences, Jiroft, Iran.
No abstract available in PubMed .
さらに関連する動画
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
08:47Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
関連する概念動画
Pharmacogenomics: Identification of New Drug Targets
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease II: Pathophysiology
Chemotaxis and Direction of Cell Migration
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
